UPADACITINIB for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 732 adverse event reports in the FDA FAERS database where UPADACITINIB was used for Psoriasis.
Most Reported Side Effects for UPADACITINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pain | 4,444 | 6.8% | 97 | 1,079 |
| Arthralgia | 3,815 | 5.8% | 92 | 882 |
| Drug ineffective | 3,384 | 5.2% | 42 | 603 |
| Covid-19 | 2,978 | 4.5% | 126 | 1,022 |
| Rheumatoid arthritis | 2,730 | 4.2% | 98 | 633 |
| Pain in extremity | 2,353 | 3.6% | 86 | 521 |
| Fatigue | 2,153 | 3.3% | 96 | 576 |
| Fall | 2,081 | 3.2% | 48 | 944 |
| Surgery | 2,037 | 3.1% | 3 | 261 |
| Therapy interrupted | 1,741 | 2.7% | 2 | 67 |
| Pneumonia | 1,645 | 2.5% | 195 | 1,108 |
| Headache | 1,574 | 2.4% | 90 | 400 |
| Death | 1,468 | 2.2% | 1,414 | 123 |
| Back pain | 1,461 | 2.2% | 14 | 431 |
| Peripheral swelling | 1,455 | 2.2% | 88 | 420 |
Other Indications for UPADACITINIB
Rheumatoid arthritis (33,555)
Product used for unknown indication (9,737)
Dermatitis atopic (5,263)
Colitis ulcerative (4,800)
Crohn's disease (4,390)
Psoriatic arthropathy (3,556)
Ankylosing spondylitis (1,440)
Eczema (261)
Rheumatoid factor positive (208)
Axial spondyloarthritis (199)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)